Drugs / Sculptra Aesthetic
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07205744 | Aug 2025 → Aug 2026 overdue | — | Erevna Innovations Inc. | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sculptra Aesthetic | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07205744 ↗ |
| Known as | PLLA-SCA | “Sculptra® Aesthetic (PLLA-SCA) is manufactured by Galderma Laboratories.” NCT07205744 ↗ |